Zeto, Inc.

Industry
Medical Equipment Manufacturing
Founded Year
2014
Headquarters
4701 Patrick Henry Dr, Building #25, Santa Clara, CA 95054, United States
Employee Count
67

Key People

Assessment

Team
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with significant industry expertise.

The leadership team, including the founder and key executives, brings over a decade of experience in the medical technology sector, enhancing the company's strategic direction and operational execution.

Clinical Need
Aspect: Very Strong
Summary: Zeto addresses a critical need for efficient and accessible EEG monitoring.

Traditional EEG procedures are time-consuming and require trained technicians. Zeto's wireless, dry electrode headset simplifies the process, reducing setup time and improving patient experience, thereby meeting a significant clinical need.

Competition
Aspect: Somewhat crowded
Summary: The EEG monitoring market has several players, but Zeto's innovation differentiates it.

The EEG monitoring market includes multiple competitors. However, Zeto's FDA-cleared, wireless, dry electrode headset offers a unique value proposition that sets it apart from traditional solutions.

Technical Challenge
Aspect: Moderate
Summary: Developing a wireless, dry electrode EEG headset involves moderate technical challenges.

Creating a wireless EEG headset with dry electrodes requires overcoming challenges related to signal quality and device comfort. Zeto's successful FDA clearance indicates these challenges have been effectively addressed.

Patent
Aspect: Strong
Summary: Zeto holds strong patents protecting its innovative EEG technology.

Zeto's patented technology safeguards its unique approach to EEG monitoring, preventing competitors from replicating its innovations and ensuring market exclusivity.

Financing
Aspect: Well-funded
Summary: Zeto has secured substantial funding, indicating strong financial health.

With a total funding of $83 million, including a recent $31 million Series B round led by MindWorks Global, Zeto is well-positioned to invest in product development, commercialization, and scaling operations.

Regulatory
Aspect: 510k/PMA
Summary: Zeto's products have received FDA 510(k) clearance, facilitating market entry.

The FDA 510(k) clearance for Zeto's EEG headset validates its safety and efficacy, enabling the company to market its product in the U.S. and providing a foundation for seeking approvals in other regions.

Opportunity Rollup

Odds of Success
4
Peak Market Share
5.7
Segment CAGR
4.9%
Market Segment
Neurology Devices
Market Sub Segment
EEG Monitoring Equipment
Year Post Launch Market Penetration (%)
1 0.29
2 0.86
3 2.00
4 3.99
5 5.70

Key Takeaway

Zeto's innovative EEG solutions, strong leadership, and substantial funding position it well to capitalize on the growing demand for accessible brain monitoring technologies.